Berkowitz, S. D., Granger, C. B., Pieper, K. S., Topol, E. J., & Califf, R. M. (1997). Incidence and predictors of bleeding after antithrombin therapy for acute coronary syndromes: The GUSTO II trials. THROMBOSIS AND HAEMOSTASIS, PS963–PS963.

Berkowitz, S. D., C. B. Granger, K. S. Pieper, E. J. Topol, and R. M. Califf. “Incidence and predictors of bleeding after antithrombin therapy for acute coronary syndromes: The GUSTO II trials.” THROMBOSIS AND HAEMOSTASIS, June 1, 1997, PS963–PS963.

Berkowitz SD, Granger CB, Pieper KS, Topol EJ, Califf RM. Incidence and predictors of bleeding after antithrombin therapy for acute coronary syndromes: The GUSTO II trials. THROMBOSIS AND HAEMOSTASIS. 1997 Jun 1;PS963–PS963.

Berkowitz, S. D., et al. “Incidence and predictors of bleeding after antithrombin therapy for acute coronary syndromes: The GUSTO II trials.” THROMBOSIS AND HAEMOSTASIS, SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN, June 1997, pp. PS963–PS963.

Berkowitz SD, Granger CB, Pieper KS, Topol EJ, Califf RM. Incidence and predictors of bleeding after antithrombin therapy for acute coronary syndromes: The GUSTO II trials. THROMBOSIS AND HAEMOSTASIS. SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN; 1997 Jun 1;PS963–PS963.